Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CAPRNASDAQ:INNVNASDAQ:PDSBNASDAQ:SNNAOTCMKTS:WCUI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCAPRCapricor Therapeutics$10.10+0.7%$10.58$3.52▼$23.40$461.14M0.821.97 million shs758,397 shsINNVInnovAge$4.43+6.7%$3.80$2.60▼$6.69$598.09M0.5150,643 shs29,140 shsPDSBPDS Biotechnology$1.34+5.2%$1.46$0.85▼$4.42$61.07M1.21471,591 shs141,463 shsSNNASienna Biopharmaceuticals$0.14$0.14$0.06▼$3.80$4.20M2.671.87 million shs13.32 million shsWCUIWellness Center Usa$0.00$0.00$0.00▼$0.00$79K4.89N/AN/A13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCAPRCapricor Therapeutics0.00%-9.46%-29.06%+9.97%+109.88%INNVInnovAge0.00%+13.01%+10.20%+45.72%-13.14%PDSBPDS Biotechnology0.00%-5.25%-20.95%+38.70%-57.18%SNNASienna Biopharmaceuticals0.00%0.00%0.00%0.00%0.00%WCUIWellness Center Usa0.00%0.00%0.00%+450.00%+10.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCAPRCapricor Therapeutics3.3483 of 5 stars4.63.00.00.02.00.80.6INNVInnovAge0.6382 of 5 stars1.82.00.00.00.01.70.6PDSBPDS Biotechnology2.326 of 5 stars3.74.00.00.02.30.00.0SNNASienna BiopharmaceuticalsN/AN/AN/AN/AN/AN/AN/AN/AWCUIWellness Center UsaN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCAPRCapricor Therapeutics 3.11Buy$32.22219.19% UpsideINNVInnovAge 1.50Reduce$5.0012.87% UpsidePDSBPDS Biotechnology 3.33Buy$9.00573.65% UpsideSNNASienna Biopharmaceuticals 0.00N/AN/AN/AWCUIWellness Center Usa 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest PDSB, INNV, SNNA, CAPR, and WCUI Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/1/2025PDSBPDS BiotechnologyHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$13.006/30/2025CAPRCapricor TherapeuticsAlliance Global PartnersSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$20.006/26/2025CAPRCapricor TherapeuticsB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$21.006/25/2025CAPRCapricor TherapeuticsB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy6/25/2025CAPRCapricor TherapeuticsJones TradingSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$40.00 ➝ $29.006/24/2025CAPRCapricor TherapeuticsHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$77.006/23/2025CAPRCapricor TherapeuticsOppenheimerSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOutperform ➝ Outperform$43.00 ➝ $22.006/17/2025CAPRCapricor TherapeuticsRoth CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$31.006/13/2025CAPRCapricor TherapeuticsHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$77.006/11/2025PDSBPDS BiotechnologyHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$13.005/20/2025CAPRCapricor TherapeuticsRoth CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$31.00(Data available from 7/7/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCAPRCapricor Therapeutics$22.27M20.71N/AN/A$3.20 per share3.15INNVInnovAge$763.85M0.78N/AN/A$2.04 per share2.17PDSBPDS BiotechnologyN/AN/AN/AN/A$0.51 per shareN/ASNNASienna BiopharmaceuticalsN/AN/AN/AN/A$1.27 per shareN/AWCUIWellness Center Usa$660K0.12N/AN/AN/A∞Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCAPRCapricor Therapeutics-$40.47M-$1.42N/AN/AN/A-181.71%-62.42%-48.36%8/6/2025 (Estimated)INNVInnovAge-$21.34M-$0.23N/A73.83N/A-3.75%-11.91%-5.85%9/9/2025 (Estimated)PDSBPDS Biotechnology-$37.61M-$0.94N/AN/AN/AN/A-150.59%-69.15%8/12/2025 (Estimated)SNNASienna Biopharmaceuticals-$73.47M-$3.59N/AN/AN/AN/A-177.36%-52.22%N/AWCUIWellness Center Usa-$750KN/A0.00∞N/AN/AN/AN/AN/ALatest PDSB, INNV, SNNA, CAPR, and WCUI EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2025Q1 2025PDSBPDS Biotechnology-$0.25-$0.21+$0.04-$0.21N/AN/A5/13/2025Q1 2025CAPRCapricor Therapeutics-$0.33-$0.53-$0.20-$0.53$3.16 million$2.73 million5/6/2025Q3 2025INNVInnovAge-$0.02-$0.08-$0.06-$0.08$214.09 million$218.14 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCAPRCapricor TherapeuticsN/AN/AN/AN/AN/AINNVInnovAgeN/AN/AN/AN/AN/APDSBPDS BiotechnologyN/AN/AN/AN/AN/ASNNASienna BiopharmaceuticalsN/AN/AN/AN/AN/AWCUIWellness Center UsaN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCAPRCapricor TherapeuticsN/A6.556.55INNVInnovAge0.040.780.78PDSBPDS Biotechnology0.292.332.33SNNASienna BiopharmaceuticalsN/A15.2715.27WCUIWellness Center UsaN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCAPRCapricor Therapeutics21.68%INNVInnovAge12.26%PDSBPDS Biotechnology26.84%SNNASienna Biopharmaceuticals17.36%WCUIWellness Center Usa0.01%Insider OwnershipCompanyInsider OwnershipCAPRCapricor Therapeutics10.50%INNVInnovAge1.40%PDSBPDS Biotechnology9.20%SNNASienna Biopharmaceuticals27.20%WCUIWellness Center Usa15.70%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCAPRCapricor Therapeutics10145.68 million40.88 millionOptionableINNVInnovAge2,350135.01 million133.12 millionOptionablePDSBPDS Biotechnology2045.71 million41.51 millionOptionableSNNASienna Biopharmaceuticals3930.91 millionN/ANot OptionableWCUIWellness Center Usa8143.19 million120.71 millionNot OptionablePDSB, INNV, SNNA, CAPR, and WCUI HeadlinesRecent News About These CompaniesWest Monroe Honors Local Businesses with “Yard of the Month” Award for Outstanding Beautification to The Wellness CenterJuly 5 at 3:42 PM | msn.comAvas Wellness Center and Spa to Anchor a Growing Wellness-Driven Ecosystem in AlibaugJuly 2, 2025 | devdiscourse.comDErie Cancer Wellness Center Free Outdoor Summer Wellness Series July 10July 1, 2025 | erienewsnow.comE‘Shocked’: North Portland Wellness Center scorched by 3-alarm fireJune 10, 2025 | msn.comWildcat Wellness Center set to close in July for summer breakJune 4, 2025 | msn.comSenior wellness expo draws increased attendance at YMCA Wellness CenterMay 21, 2025 | msn.comLumiClinics Behavioral Wellness Center Revolutionizes Mental Health Care with Integrated ApproachMay 17, 2025 | news.marketersmedia.comNCancer Wellness Center of NEPA holds Annual WalkMay 12, 2025 | timesleader.comTCancer Wellness Center gears up for major walk fundraiserMay 7, 2025 | msn.comWellness Center attendance upApril 16, 2025 | sdsucollegian.comSMCCTC Plans New Health and Wellness CenterApril 11, 2025 | businessjournaldaily.comBRegional Wellness Center project planning on pause amid funding uncertaintyApril 11, 2025 | duboiscountyfreepress.comDVictorville’s Wellness Center receives major funding from San Bernardino CountyApril 11, 2025 | msn.comUSD To Host Wellness Center Natatorium Grand Opening And Ribbon CuttingApril 11, 2025 | plaintalk.netPSam Raan Spa & Wellness Center Wins a 2025 Global Recognition Award for Exceptional Service ExcellenceMarch 31, 2025 | news.marketersmedia.comNAgeWell Services continuing its mission despite Wellness Center and Cafe closureMarch 28, 2025 | msn.comMultimillion dollar transformation set for Norfolk Fitness and Wellness CenterMarch 28, 2025 | wtkr.comWAgeWell Services will close Wellness Center, Driftwood Café amid budget concernsMarch 27, 2025 | msn.comMid-America Carpenters Regional Council and Premise Health Celebrate Grand Opening of Kansas City Wellness CenterMarch 12, 2025 | finance.yahoo.comNASCAR Legends Jimmie Johnson, Richard Petty Spotted at Martin Truex Jr.’s Late Partner’s Wellness Center OpeningFebruary 16, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimePDSB, INNV, SNNA, CAPR, and WCUI Company DescriptionsCapricor Therapeutics NASDAQ:CAPR$10.10 +0.08 (+0.75%) Closing price 07/3/2025 03:54 PM EasternExtended Trading$10.18 +0.08 (+0.84%) As of 04:13 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Capricor Therapeutics, Inc. (NASDAQ:CAPR) is a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class biological therapeutics for the treatment of rare disorders. Capricor's lead candidate, CAP-1002, is an allogeneic cell therapy that is currently in clinical development for the treatment of Duchenne muscular dystrophy. Capricor has also established itself as one of the leading companies investigating the field of extracellular vesicles and is exploring the potential of CAP-2003, a cell-free, exosome-based candidate, to treat a variety of disorders. InnovAge NASDAQ:INNV$4.43 +0.28 (+6.75%) Closing price 07/3/2025 01:04 PM EasternExtended Trading$4.73 +0.30 (+6.75%) As of 07/3/2025 04:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in its homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management. The company serves participants in the United States; and operates PACE centers in Colorado, California, New Mexico, Pennsylvania, Florida, and Virginia. The company was formerly known as TCO Group Holdings, Inc. and changed its name to InnovAge Holding Corp. in January 2021. InnovAge Holding Corp. was founded in 2007 and is headquartered in Denver, Colorado.PDS Biotechnology NASDAQ:PDSB$1.34 +0.07 (+5.20%) Closing price 07/3/2025 03:46 PM EasternExtended Trading$1.35 +0.01 (+1.05%) As of 04:53 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, developing a pipeline of targeted cancer immunotherapies in the United States. The company's lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, and human papillomavirus associated malignancies. It also develops various product candidates, which are in preclinical trials, including PDS0102, an investigational immunotherapy utilizing tumor-associated and immunologically active T cell receptor gamma alternate reading framed protein (TARP) for treating prostate and breast cancers; and PDS0103 for ovarian, colorectal, lung, and breast cancers. In addition, the company is developing PDS01ADC, a novel investigational Interleukin 12 fused antibody-drug conjugate that enhances the proliferation, potency, and longevity of T cells in the tumor microenvironment; and PDS0104, a novel investigational Tyrosinase-related Protein 2 targeted immunotherapy that stimulates a potent targeted T cell attack against melanoma. Further, the company provides PDS0202, a novel investigational influenza vaccine that generates broad and robust antibody and T cell responses that provide protection against continually evolving strains of seasonal flu and potentially emerging pandemic flu. It has a license and collaboration agreements with National Institutes of Health, Merck Eprova AG, The U.S. Department of Health and Human Services, and MSD International GmbH. The company was founded in 2005 and is based in Princeton, New Jersey.Sienna Biopharmaceuticals NASDAQ:SNNASienna Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that focuses on the discovery, clinical development, and commercialization of aesthetics and medical dermatology. Its products include Topical by Design platform for patients with inflammatory skin diseases and other dermatologic and aesthetic conditions through SNA-120, SNA-125, and SNA-001. The company was founded by Todd Harris and Frederick C. Beddingfield III on July 27, 2010 and is headquartered in Westlake Village, CA.Wellness Center Usa OTCMKTS:WCUI$0.0006 0.00 (0.00%) As of 07/3/2025Wellness Center USA, Inc. engages in the healthcare and medical business in the United States and internationally. The company operates through Medical Devices; and Authentication and Encryption Products and Services segments. It is primarily involved in the marketing and distribution of online sports and nutrition supplements. The company also designs, develops, manufactures, markets, and distributes targeted ultraviolet phototherapy devices that include Psoria-Light, which is used in targeted PUVA photochemistry and UVB phototherapy for the treatment of skin conditions, such as psoriasis, vitiligo, atopic dermatitis, seborrheic dermatitis, and leukoderma. In addition, it offers intelligent microparticles, which provide technologies within the security and supply chain management vertical sectors; and ActiveDuty, a data intelligence service comprising proprietary, unprecedented, and actionable technology, which include a suite of analytical tools, such as artificial intelligence and social psychology for industries, companies, and agencies. The company was incorporated in 2010 and is based in Tucson, Arizona. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 06/30 - 07/04 The Apple Comeback Will Be Better Than the Setback Micron’s Big Q3 Drives Applied Materials’ Bullish Outlook Correction Equals Opportunity in Domino’s Pizza Stock Why Occidental's Price Dip Signals a Buying Opportunity Qualcomm’s Hold Rating Misses Strong Growth Story Rigetti Computing: Cantor's Bullish Call May Be Just the Start Insider Selling at NVIDIA Could Turn Into an Opportunity Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.